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Abstract
Background: We investigated the oxidative modifications of lipids, proteins and DNA, potential molecular targets
of oxidative stress, in two lymphoblastoid cell lines: B95-8 and Raji, after EBV lytic cycle induction. Conjugated
dienes level was measured as biomarker of lipid peroxidation. Malondialdehyde adduct and protein carbonyl levels,
as well as protein thiol levels were measured as biomarkers of protein oxidation. DNA fragmentation was evaluated
as biomarker of DNA oxidation.
Results: After 48 h (peak of lytic cycle), a significant increase in conjugated dienes level was observed in B95-8 and
Raji cell lines (p = 0.0001 and p = 0.019 respectively). Malondialdehyde adduct, protein carbonyl levels were
increased in B95-8 and Raji cell lines after EBV lytic cycle induction as compared to controls (MDA-adduct: p =
0.008 and p = 0.006 respectively; Carbonyl: p = 0.003 and p = 0.0039 respectively). Proteins thiol levels were
decreased by induction in B95-8 and Raji cell lines (p = 0.046; p = 0.002 respectively). DNA fragmentation was also
detected in B95-8 and Raji cell lines after EBV lytic cycle induction as compared to controls.
Conclusion: The results of this study demonstrate the presence of increased combined oxidative modifications in
lipids, proteins in B95-8 and Raji cells lines after EBV lytic cycle induction. These results suggest that lipid
peroxidation, protein oxidation and DNA fragmentation are generally induced during EBV lytic cycle induction and
probably contribute to the cytopathic effect of EBV.
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Background
Epstein Barr virus (EBV) is a ubiquitous gammaherpes-
virus that infects more than 90% of the human popula-
tion. The EBV can infect its target cells in both a latent
and a lytic mode. The latent cycle is characterized by
the expression of six Epstein-Barr nuclear antigens
(EBNAs), three latent membrane proteins LMP1,
LMP2A, and LMP2B, two untranslated RNAs (EBER),
and a family of transcripts from the BMH1A region of
the genome [1,2]. Upon EBV reactivation, two key
immediate early (IE) lytic genes, BZLF1 and BRLF1,
encoding Zta (BZLF1 transcription activator) and Rta
(BRLF1 transcription activator) respectively, are
transcribed, and consequently activate several down-
stream viral promoters and lead to an ordered cascade
of viral gene expression [3]. The latent form of EBV can
be induced to enter the lytic form in vitro by treatment
with various chemicals, including 12- 0-tetradecanoyl-
phorbol-13-acetate (TPA) [4], halogenated pyrimidine
[5], n-butyrate [6], calcium ionophores [7]. These indu-
cers act through different signalling pathways to transac-
tivate gene of EBV, which encodes the ZEBRA protein.
The expression of ZEBRA protein then transactivates
immediate early and early genes of EBV, and thereby
induces the lytic cycle [8,9].
EBV is associated with a spectrum of malignancies of
lymphoid and epithelial cell origin, such as Burkitt’s
lymphoma [10], nasopharyngeal carcinoma (NPC) [11],
and gastric carcinoma [12]. The role of EBV in malig-
nancy was largely studied and latent EBV antigens such
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as LMP or EBNA were generally incriminated [13-15].
The fact that all EBV-associated malignancies have a
predominantly latent pattern of viral gene expression led
to the assumption that only the latent phase of viral
gene expression is important during the development of
EBV associated malignancies. Nevertheless, a small
number of lytically infected cells are frequently detected
in biopsies of EBV-associated lymphoproliferative dis-
eases (LPDs) in immunosuppressed individuals. Lytic
replication has been observed at the site of tumor devel-
opment in posttransplant lymphoproliferative disorder
(PTLD) [16] as well as in Burkitt’s lymphoma [17]. In
addition, Hong et al. have shown that EBV mutants that
cannot undergo lytic viral replication are defective in
promoting EBV-mediated LPD [18]. Moreover, an
increasing number of diseases were found to be asso-
ciated with EBV lytic cycle and exhibit an oxidative
stress state at the same time, such as rheumatoid arthri-
tis [19,20], and infectious mononucleosis [21].
A lot of evidences demonstrated that EBV is implicated
in the genesis of oxidative damages in vitro or in vivo
and that could participate in the pathogenicity of the
EBV. An excessive production of reactive oxygen specie
(ROS) was highlighted in EBV positive lymphoblastoid
cell lines transformed in vitro [22] or derived from Bur-
kitt’s lymphoma [23]. In addition, oxidative damage was
determined during the course of acute EBV infection [24]
and replication [25] in lymphoblastoid cell lines.
Oxygen free radicals or, more generally, ROS, are pro-
ducts of normal cellular metabolism. ROS are well
recognised for playing a dual role as both deleterious
and beneficial species, since they can be either harmful
or beneficial to living systems [26]. Damage has been
reported to occur on all components of biological sys-
tems (DNA, RNA, lipids, proteins, carbohydrates, low-
molecular-mass species, antioxidants) due to the high
reactivity of many oxidants [27]. Proteins are likely to be
major targets, as a result of their abundance in cells
(proteins compose 70% of the drymass of most cells),
and their rapid rates of reaction both with many radicals
and with other oxidants (peroxides, excited states, per-
oxynitrite, chloramines, ozone) [27]. Otherwise, DNA
damage is one of the more reliable markers to detect
oxidative stress [28,29].
However, there is no adequate knowledge in the litera-
ture about protein and DNA modifications in cells after
EBV lytic cycle induction. Many different types of pro-
tein oxidative modifications can be induced by free radi-
cals [30,31]. Protein carbonyl, protein thiol formation
had been accepted as a phenomenon of protein oxida-
tion [32].
This study sought the effect of virus replication on
lipids, proteins and DNA oxidation of two lymphoblas-
toid cells lines B95-8 and Raji. The induction of the
lytic cycle was done by TPA. The lipids, proteins and
DNA damages were then determined after 48 h, the
peak of lytic cycle [33], by measuring the level of conju-
gated dienes as parameters of lipids peroxidation, mal-
ondialdehyde adduct, protein carbonyl and protein thiol
as parameters of proteins oxidation, and the DNA frag-
mentation assays as marker of DNA damage.
Results
Evaluation of lipid peroxidation (LPO)
CD level was measured 48 h after induction of the lytic
cycle to evaluate lipid peroxidation. The study was per-
formed in parallel cultures with or without TPA treat-
ment. Our data show a significant rise in CD level in
B958 and Raji cell lines after EBV lytic cycle induction
(p = 0.0001 and p = 0.019 respectively) (Figure 1).
A comparison of differences between basal and post
induction CD level was monitored. A significant rise in
CD level was observed in B958 cell line as compared to
CD level in Raji cell line (p = 0.01).
Evaluation of MDA adduct
MDA adduct level was monitored in B958 and Raji
cell lines after 48 h of lytic cycle induction. MDA
adduct level was low in B958 and Raji cell line with-
out TPA treatment. Our data show a significant rise
in MDA adduct level in B958 and Raji cell lines after
EBV lytic cycle induction (p = 0.008 and p = 0.006)
(Figure 2).
The deviation between basal level and post induction
level of MDA adduct was higher in B958 than in Raji
cell line. (p = 0.08).
Evaluation of protein carbonyl and SH level
PC and SH levels were assessed in B958 and Raji cells
after 48 h of lytic cycle induction to determine proteins
oxidation. A significant rise in PC level was observed in
B958 and Raji cell lines, 48 h after EBV lytic cycle
induction as compared to controls (p = 0.0030 and p =
0.0039 respectively). Protein thiol level was decreased by
induction in B95-8 and Raji cell lines (p = 0.046; p =
0.002 respectively) (Figure 3 and 4).
As evidenced with CD and MDA adduct, our result
show a significant rise in carbonyl level as well as a sig-
nificant decrease in SH level in B95-8 than in Raji cell
line (p = 0.01 and p = 0.01 respectively).
Evaluation of DNA fragmentation
To investigate the DNA fragmentation, B95-8 and Raji
cells were treated with 8 nM TPA, and DNA was iso-
lated and analyzed by agarose gel electrophoresis. These
experiments demonstrated that DNA from B95-8 and
Raji cells after EBV lytic cycle induction was fragmented
(Figure 5).
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Discussion
EBV is implicated in the generation of oxidative stress
both in vivo, in some EBV associated malignancies and
diseases such as NPC [34] and in vitro, in EBV-infected
cell lines [23].
In a previous report, we demonstrated that EBV lytic
cycle induction in lymphoblastoid cell line is responsible
for the occurrence of oxidative stress by an increase in
MDA level and a disturbance of SOD and CAT activ-
ities [25]. However, the direct role of EBV replication or
the expression of lytic viral antigens in the genesis of
proteins and DNA oxidation has not been investigated.
For these reasons, we investigated the effect of lytic
cycle induction on the proteins oxidation, lipids
peroxidation and DNA fragmentation of two lympho-
blastoid cells lines: B958 and Raji. We chose to work
with the minimal and sufficient concentration of
TPA inducing EBV lytic cycle which is 8 nM. This
concentration is very low, compared to the concen-
trations that will induce oxidative stress (1.5-15 μM)
[22], and this dose did not trigger stress in the EBV
negative cell line (DG75) treated in the same condi-
tions [35].
A significant rise in CD levels was observed in Raji
and B958 cell lines 48 h after EBV lytic cycle induction.
We observed an increase in CD level in the two cell
lines, indicating the presence of oxidative stress as a
consequence of induction of the lytic cycle.
Figure 2 Illustrates MDA adduct level. MDA adduct level was measured in B958 and Raji cell line after 48 h of lytic cycle induction.
Malondialdehyde adduct level was increased in B95-8 and Raji cell lines after EBV lytic cycle induction as compared to controls (p = 0.008 and p
= 0.006 respectively).
Figure 1 Illustrates conjugated diene level. To evaluate lipid peroxidation, CD level was measured 48 h after induction of the lytic cycle. The
study was performed in parallel cultures with or without TPA treatment. After 48 h, a significant increase in CD level was observed in B95-8 and
Raji cell lines (p = 0.019 and p = 0.0001 respectively).
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Many different types of protein oxidative modifica-
tions can be induced by free radicals. Their oxidative
damage can be evaluated by different ways, such as pro-
tein carbonyls, MDA adduct as well as SH level.
Protein carbonyls determination has been particularly
proposed as a marker of oxidative stress, since they
form early and they are generally stable [32].
Our data have show a significant rise in PC and MDA
adduct levels as well as a decrease in SH level in Raji and
B958 cells line, 48 h after EBV lytic cycle induction. Taken
together, these results demonstrate protein oxidation dur-
ing lytic cycle induction. Oxidized proteins cause major
physiological perturbations including loss of structure and
function [36]. Besides, previous studies have show that
oxidatively modified proteins lead to the genesis of new
epitopes that incite autoantibody production. Protein oxi-
dation causes conformational changes, which include the
exposure of the hydrophobic regions of the proteins,
explaining the increased interaction between antibodies
and antigens after oxidation [36]. In fact, an increasing
Figure 3 Illustrates protein carbonyl level. PC level was assessed in B958 and Raji cell line after 48 h of lytic cycle induction to determine
protein oxidation. A significant rise in PC level was observed in B958 and Raji cell line 48 h after EBV lytic cycle induction as compared to
controls (p = 0.0030 and p = 0.0039 respectively).
Figure 4 Illustrates protein thiol level. Proteins thiol was monitored in B958 and Raji cell lines after 48 h of lytic cycle induction. Proteins thiol
level was decreased by induction in B95-8 and Raji cell lines (p = 0.046; p = 0.002 respectively).
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number of autoimmune diseases were found to be asso-
ciated with EBV lytic cycle and exhibit an oxidative stress
state at the same time, such as rheumatoid arthritis [36].
Our data demonstrated that oxidative damage was
higher in B958 as compared to Raji cell line. Interesting,
B958 cell line can produce active EBV viral particles
[37], contrarily to Raji cell line. So, our results reinforce
our suggestion in our previous study, in which we sug-
gested that an EBV viral program further down the lytic
pathway may be responsible for observed oxidative
stress. Raji is a Burkitt’s lymphoma-derived cell line,
which does not produce viral particles, because of the
total inhibition of viral DNA synthesis [4,38]. However,
lipid peroxidation and protein oxidation were observed
after EBV lytic cycle induction, indicating that virus
replication is not required for inducing oxidative stress.
Other viral antigens, which continue to be expressed in
Raji such as BZLF1, BRLF1, DNA polymerase, TK, and
DNase, were probably responsible for the observed oxi-
dative damage [39-41].
DNA fragmentation was detected in B95-8 and Raji
cell lines after EBV lytic cycle induction as compared to
controls. In fact, DNA damage is described in biopsies
nasopharyngeal carcinoma patients [42], where EBV
seems to play a crucial role [43]. Our results are in har-
mony with Michiko study, who reported a fragmenta-
tion of chromosomal DNA during EBV lytic cycle
induction in Raji cell line [44]. Michiko suggested that
EBV-specific early proteins participate in fragmentation
of chromosomal DNA, since Phosphonoacetic acid, an
inhibitor of EBV DNA polymerase, did not inhibit frag-
mentation of chromosomal DNA.
In our study, oxidative stress causes lipid peroxidation
and protein oxidation. In addition, it is well known that
ROS induce DNA strand breaks in human lymphocytes
[45]. For these reasons, we suggest that ROS production
causes DNA fragmentation. Our results is not in contra-
diction to thus presented by Michiko, since it has been
shown that ROS regulate a spectrum of cellular
responses, including P53, heat shock proteins, transcrip-
tion factor NF-B, and AP-1 [46-51]. Among them, P53,
NF-B, and AP-1 have been reported to regulate
Epstein-Barr virus immediate-early gene BZLF-1, the
key molecule responsible for the reactivation of EBV
[49-51]. Also, we have previously reported that H202
and FeSO4 induce BZLF-1 gene expression [24]. How-
ever, whether ROS productions, during lytic cycle induc-
tion induce DNA degradation directly or indirectly by
other protein expression has to be defined.
It is well know that cytokines were among those first
reported to generate ROS in nonphagocytic cells. It is
generally accepted that ROS generated by these ligand/
receptor-initiated pathways can function as true second
messengers and mediate important cellular functions
such as proliferation and programmed cell death [52].
However, in lymphoblastoid cell lines, EBV lytic cycle
induction downregulate cytokine genes expression such
as (TNF)-a and interferon (INF)-g receptor [53,54], and
inhibits interferon regulatory factor (IRF)-7 mediated
induction of IFN-a and b genes expression [55].
In lymphoblastoid cell line, several pathways could be
a source of ROS production such as mitochondria or
NADPH oxydase. In fact, Lajeunesse et al reported that
BZLF-1 gene expression in human cell lines results in a
dramatic reorganization of mitochondria accompanied
by a significant alteration of mitochondrial membrane
potential, which can be a sign of an increase in ROS
production caused by the damage of the mitochondrial
electron transport system [56].
Martin et al. reported that infection of neutrophils by
EBV in vitro, rapidly reduces their survival, as confirmed
by DNA staining with propiduim iodide and Hoechst
33342 and by DNA analysis [57]. Larochelle et al. demon-
strated that in vitro EBV infection drastically increases
Figure 5 Agarose gel analysis of DNA from B958 and Raji cells.
The study was performed in parallel cultures with or without TPA
treatment. TPA treatment (lanes 1 (B958) and 3 (Raji)), untreated cells
(lanes 2 (B958) and 4 (Raji)) and untreated lymphocytes used as
control (lane 5). B95-8 and Raji cells were harvested at 48 h after EBV
lytic cycle induction, and analyzed by 2% agarose gel. EBV lytic cycle
induction causes DNA fragmentation in B95-8 as well as Raji cells.
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the rate of spontaneous neutrophils apoptosis [58]. Flow
cytometry analyses have revealed that 77% of neutrophils
were apoptotic after 20 h post-infection, as compared to
22% in uninfected cells. However, the mechanism initiat-
ing the apoptotic process in EBV infected neutrophils
remains unknown. Valko et al. reported an inhibition of
protein kinase C (PKC) translocation and activation dur-
ing EBV lytic cycle. It is well know that PKC was
described as a source of ROS production [26].
In lyphoblastoid cell line, we described an oxidative
stress status, 48 h after EBV activation, which corre-
spond of a peak of EBV lytic cycle induction and we
don’t observe death of cells.
Hitochi et al. reported that treatment of Raji cells with
flavonoids, quercetin resulted in effective inhibition of
EA induction by TPA. None of the other flavonoids
such as rutin, catechin and fi-naphthoflavone affected
the induction of EBV-EA by TPA [59].
We reported that EBV replication induced oxidative
stress in lymphoblastoid cell lines. In a previous study
we have demonstrated that oxidative stress caused EBV
lytic cycle induction as demonstrated by BZLF-1 gene
expression. Thus, a vicious cycle may be initiated,
whereby replication of EBV and ROS production amplify
one another. This may lead to an increase in the num-
ber of EBV-infected cells and thus favor the develop-
ment of EBV associated diseases, especially in
immunodeficient individuals. The use of therapeutic
drugs such as chemotherapy or immunosuppressive
drug, which are known to induct oxidative stress may
up-regulate the expression of BZLF-1, and may be a risk
factor for EBV reactivation [60,61]. Inhibition of ROS
may be useful in prevention or in the treatment of EBV-
induced diseases.
In summary, EBV lytic cycle induction was able to
damage lipids, proteins and DNA, crucial biomolecules
in living cells. Same damages were observed in EBV
associated malignancies such as DNA damage in naso-
pharyngeal carcinoma biopsies patients, and proteins
modification in autoimmunes diseases. This investiga-
tion may provide important clues to the mechanisms
involved in the development of cancer and autoim-
munes deseases.
Materials and methods
Cell line and culture conditions
Cell lines and culture conditions
• Raji is a human Burkitt’s lymphoma-derived cell line,
harboring the latent form of EBV cycle [62].
• B95-8 is a lymphoblastoid cell line established from
peripheral blood lymphocytes of a cotton-top marmo-
set (Saguinus Oedipus) following in vitro infection
with EBV [37]. A small fraction (1-3%) of current
batches of B95-8 cells spontaneously enter the viral
lytic cycle.
All the cell lines were grown in RPMI 1640 medium
(Gibco) supplemented with 10% fetal calf serum
(FCS) and 2 mM L-glutamine in tissue culture flasks
(Nunc). They were passaged twice a week and kept at
37°C in a humidified atmosphere of 95% air and 5%
CO2.
TPA treatment
For the induction of the lytic cycle, 3 × 106 cells were
stimulated with 8 nM TPA for 2 h, when the cells were
in logarithmic phase growth, usually 48 h after placing
them in culture. The cells were washed two times with
Phosphate buffer saline (PBS) and further incubated for
48 h in fresh culture medium [62].
Preparation of cell extracts
Cells were centrifuged at 3,000 rpm for 10 min. The
pellet was resuspended in 500 μl of deionized water and
lysed by five cycles of sonication during 20 s at 37%
(Sonisc, vibracell).
Protein determination
Proteins were determined using the Protein Assay Kit
from Bio-Rad (France) and bovine serum albumin
served as the standard.
Conjugated Dienes
Conjugated diene level was evaluated as described by
Kurien and Scofield [63] with modification. 25 μl of
cells lysat were extracted with 3 ml chloroform/metha-
nol (2:1, v/v). After centrifugation at 3,000 rpm for 15
min, 2 ml of organic phase was transferred into another
tube and dried at 45°C. The dried lipids were dissolved
in 2 ml of methanol and absorbance at 233 nm was
determined. It corresponds to the maximum absorbance
of the extracted compounds.
Determination of protein thiol levels
Protein thiols were quantified spectrophotometrically
using 5,5-dithionitrobenzoic acid (DTNB); 250 ml of
freshly prepared 10 mM DTNB in 0.05 M phosphate
buffer pH 8, were added to 50 ml of cell lysat in 1200
ml of 0.05 M phosphate buffer. After incubation in the
dark for 15 min at room temperature, the release of 5-
thiobenzoic acid was quantified by measuring the absor-
bance at 412 nm and converted to absolute values using
N-acetyl cysteine as standard (0-0.1 mM). A correlation
coefficient of r2 = 0.999 was obtained. The absorbance
of samples lacking DTNB was subtracted to account for
the background absorbance at 412 nm. Samples were
analysed in duplicate.
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Detection of MDA-protein
The MDA content was assessed by colorimetric assay, as
described by Palacio et al [64]. This assay measures the
MDA bound to proteins. In brief, cells lysats were preci-
pitated twice with sulfuric acid and phosphotungstic
acid. After centrifugation, the pellet was diluted with
800 ml of distilled water. Then, 10 ml of 0.14 mM ethy-
lenediaminetetraacetic acid (EDTA), 80 ml of 0.2% buty-
lated hydroxytoluene in ethanol (BHT) and 200 ml of
1% thiobarbituric acid (TBA) were added and incubated
at 100°C for 60 min. An equal volume was extracted
with butanol and centrifuged. Finally, 250 ml were
removed from the butanolic phase and absorbances at
540 and 620 nm were determined with a Biochrom
Libra S32 spectrophotometer. 1,1,3,3-Tetraethoxypro-
pane (Sigma) was used as standard. A standard curve
(0.05, 0.1, 0.25, 0.5, 1, 2.5, 5 nM) was included in every
assay. A correlation coefficient of r2 = 0.989 was
obtained. All the samples were treated in duplicate and
the results are given as the mean values.
Protein carbonyl (PC) levels
PC levels were measured according to the method based
on spectrophotometric detection of the reaction of 2,4-
dinitrophenylhydrazine (DNPH) with protein carbonyl
to form protein hydrazones [30]. Briefly, after precipita-
tion of protein with an equal volume of 1% trichloroace-
tic acid, the pellet was resuspended in 10 mM DNPH in
2 N HCl or with 2 N HCl as control blank. Next, after
the washing procedure with 1:1 ethanol/ethylacetate, the
final pellet was dissolved in 6 M guanidine. The carbo-
nyl group was determined from the absorbance at 370
nm. The results were expressed as nanomoles of carbo-
nyl groups per milligram of protein with an extinction
coefficient of 22,000 M1 cm1.
DNA fragmentation assay
After EBV lytic cycle induction, B958 and Raji cells were
lysed in a buffer containing 10 mM Tris (pH 7.4), 150
mM NaCl, 5 mM EDTA and 0.5% Triton X-100 for 30
min on ice. Lysates were vortexed and cleared by centri-
fugation at 10 000 g for 20 min. Fragmented DNA in
the supernatant was extracted with an equal volume of
neutral phenol chloroform isoamyl alcohol mixture
(25:24:1) and analyzed electrophoretically on 2% agarose
gels containing 0.1 mg/ml of ethidium bromide [65].
Statistical analysis
Statistical analysis was carried out by Student’s t-test
value, to assess the statistical significance of the
obtained differences between treated and non-treated
cells. A p < 0.05 was considered to be statistically
significant.
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